| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 10/02/2008 | WO2008117862A1 Novel (2-aminophenyl)pyridinecarboxamide derivative having urea structure |
| 10/02/2008 | WO2008117826A1 Compound for organic electroluminescent device and organic electroluminescent device |
| 10/02/2008 | WO2008117303A1 Indole derivatives and their metal conjugates and uses thereof |
| 10/02/2008 | WO2008117148A1 Substituted oxadiazole analogs as calcium channel antagonists |
| 10/02/2008 | WO2008117079A1 Antimicrobial compounds based upon 4-aminoquinoline |
| 10/02/2008 | WO2008117051A1 S-6-meth0xy-2- (2- (3- (pyrimid-2-yl) is0xaz0l-5-yl) pyrrolidin-1-yl) -4- (5-methyl-ih-pyrazol-s-ylamino) pyrimidine and polymorphic forms thereof as modulators of the insulin-like growth |
| 10/02/2008 | WO2008116831A1 Quinoline compounds suitable for treating didorders that respond to modulation of the serotonin 5-ht6 receptor |
| 10/02/2008 | WO2008116620A1 8-oxy-quinoline derivatives as bradykinin b2 receptor modulators |
| 10/02/2008 | WO2008116308A1 Quinolone and tetrahydroquinoline and related compounds having nos inhibitory activity |
| 10/02/2008 | WO2008080891A3 Process for the synthesis of derivatives of 3-amino-tetrahydrofuran-3-carboxylic acid and use thereof as medicaments |
| 10/02/2008 | WO2008075172A3 Nicotinamide derivatives as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases |
| 10/02/2008 | WO2008075068A3 Acylaminopyrazoles as fgfr inhibitors |
| 10/02/2008 | WO2008054233A3 Process for the preparation of docetaxel |
| 10/02/2008 | WO2008053194A3 Pyridine carboxamides as 11-beta-hsd1 inhibitors |
| 10/02/2008 | US20080242715 Psychological disorders such as schizophrenia and sexual disorders |
| 10/02/2008 | US20080242704 selectively modulate, regulate, and/or inhibit signal transduction; potent and selective c-kit, bcr-abl and Fit-3 inhibitors; diseases like cell proliferation, metabolic, allergic, cancers, degenerative, autoimmune disorders; 4-{2-[5-(Benzothiazol-2-ylammo)-2-methyl-phenylamino]-oxazol-5-yl}-benzonitrile |
| 10/02/2008 | US20080242671 Selective in presence of at least one other cathepsin isozyme; such as N-{-2-[2-(4-methoxy-phenylamino)-ethylcarbamoyl]-cyclohexyl}-3-methyl-benzamide |
| 10/02/2008 | US20080242667 e.g. N-(4-{4-[2-({3-[2-(4-Morpholinyl)ethyl]phenyl}amino)-4-pyrimidinyl]-1H-pyrazol-3-yl}phenyl)benzamide; serine/threonine kinase inhibitor; anticarcinogenic, antitumor agent |
| 10/02/2008 | US20080242666 e.g. (3R,6R)-3-(2,3-dihydro-1H-inden-2-yl)-6-(1-ethylpropyl)-1-[2(hydroxymethyl)benzyl]-piperazine-2,5-dione; preparation by cyclization |
| 10/02/2008 | US20080242664 Dna-pk inhibitors |
| 10/02/2008 | US20080242663 [3-[[2-[(3,5-dimorpholin-4-ylphenyl)amino]pyrimidin-4-yl]-methyl-amino]-4-methyl-phenyl]methanol; protein tyrosine kinase EphB4 inhibitor; inhibit DNA synthesis; antiproliferative, antitumor agent |
| 10/02/2008 | US20080242658 Inhibitors of Iap |
| 10/02/2008 | US20080242656 N-Substituted-N-Sulfonylaminocyclopropane Compounds and Pharmaceutical Use Thereof |
| 10/02/2008 | US20080241948 Mycophenolate mofetil impurity |
| 10/02/2008 | CA2681821A1 Indole carboxamides as ikk2 inhibitors |
| 10/02/2008 | CA2681771A1 Quinolone and tetrahydroquinoline and related compounds having nos inhibitory activity |
| 10/02/2008 | CA2681431A1 Amino-5-[4-(difluoromethoxy)phenyl]-5-phenylimidazolone compounds for the inhibition of .beta.-secretase |
| 10/02/2008 | CA2681206A1 8-(heteroarylmethoxy)quinoline compounds as bradykinin b2 receptor modulators |
| 10/02/2008 | CA2681030A1 Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor |
| 10/02/2008 | CA2680517A1 Novel pyridinecarboxylic acid (2-aminophenyl)amide derivative having urea structure |
| 10/01/2008 | EP1975162A1 Oxazolone derivative |
| 10/01/2008 | EP1973905A1 Compounds |
| 10/01/2008 | EP1973903A1 Substituted 4-phenylpiperidines |
| 10/01/2008 | EP1973902A2 3-heterocyclylacrylamide compounds as fabi inhibitors and antibacterial agents |
| 10/01/2008 | EP1973898A1 Pdf inhibitors |
| 10/01/2008 | EP1973888A1 Isoxazolines for controlling invertebrate pests |
| 10/01/2008 | EP1973546A2 Cholesteryl ester transfer protein inhibitors |
| 10/01/2008 | EP1732922B1 Methods for minimizing thioamide impurities |
| 10/01/2008 | CN101277953A Atives of 2-aminthiazoles and 2-aminooxazoles, processes for their preparation and their use as pharmaceuticals |
| 10/01/2008 | CN101277952A Isoxazole derivatives |
| 10/01/2008 | CN101277949A Dipeptidyl peptidase-iv inhibitors |
| 10/01/2008 | CN101277698A Quinoline derivatives as antibacterial agents |
| 10/01/2008 | CN101274929A Thrombin receptor antagonists |
| 10/01/2008 | CN100422177C Method for preparing fused oxazinones from ortho-amino aromatic carboxylic acid and a carboxylic acid in the presence of a sulfonyl chloride and pyridine |
| 10/01/2008 | CN100422160C Novel morpholine derivatives, method for production thereof and pharmaceutical preparations containing said derivatives |
| 10/01/2008 | CN100422158C Inhibitors of Akt activity |
| 10/01/2008 | CN100421665C Mitotic kinesin inhibitors |
| 10/01/2008 | CA2654898A1 New chemical compounds |
| 09/30/2008 | US7429667 suc as 5-[4-(2,5-Dichloro-phenoxy)-3-fluoro-phenylamino]-3-hydroxy-N-isopropyl-isothiazole-4-carboxamidine; anticarcinogenic agent |
| 09/30/2008 | US7429661 Intermediates for linezolid and related compounds |
| 09/30/2008 | US7429660 Induce immunology response; anticancer agents |
| 09/30/2008 | US7429609 Pyrazole compound and medicinal composition containing the same |
| 09/30/2008 | US7429607 5-HT2B receptor antagonists |
| 09/30/2008 | US7429606 Oxadiazolyl-phenoxyalkylisoxazoles, compositions thereof and methods for their use as anti-picornaviral agents |
| 09/30/2008 | US7429604 Six-membered heterocycles useful as serine protease inhibitors |
| 09/30/2008 | US7429601 Tropan-6exo-yl benzilate methobromide or a physiologically acceptable salt or derivative; chronic obstructive pulmonary disease, asthma; urogenital disorders; antihistamine, antispasmodic, and bronchodilator agents |
| 09/30/2008 | US7429599 Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK |
| 09/30/2008 | US7429596 Oxidoreductase inhibitors; anticancer agents; antiinflammatory agents |
| 09/30/2008 | US7429593 Utilities of amide compounds |
| 09/30/2008 | US7429588 Crystalline isoxazole derivative and medical preparation thereof |
| 09/30/2008 | US7429587 e.g. 2-(4-Chlorophenyl)-N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}ethenesulfonamide; blood coagulation factor and trypsin-like serine protease inhibitor; anticoagulant, antiinflammatory agent; atherosclerotic plaque, myocardial infarction and unstable angina |
| 09/30/2008 | US7429584 Furo[2.3-b]pyridine derivatives for the treatment of hyper-proliferative disorders |
| 09/30/2008 | US7429581 Pyrazole-derivatives as factor Xa inhibitors |
| 09/30/2008 | US7429579 antagonism/inhibition, of the D3 receptor; substance abuse. |
| 09/30/2008 | US7429565 Antiviral phosphonate analogs |
| 09/30/2008 | CA2417417C Method for recovery of copper from sulfidic ore materials using super-fine grinding and medium temperature pressure leaching |
| 09/25/2008 | WO2008116145A2 Soluble epoxide hydrolase inhibitors |
| 09/25/2008 | WO2008115381A1 Pyridazinone derivatives useful as glucan synthase inhibitors |
| 09/25/2008 | WO2008115369A2 Inhibitors of focal adhesion kinase |
| 09/25/2008 | WO2008115259A2 Derivatives of benzoxadiazole suitable for the treatment of cell proliferative diseases |
| 09/25/2008 | WO2008114157A1 Amino- pyridine derivatives as s1p1 /edg1 receptor agonists |
| 09/25/2008 | WO2008114023A2 Phthalazinone derivatives |
| 09/25/2008 | WO2008113255A1 Benzamide derivatives with anti-proliferative activity, pharmaceutical preparations thereof |
| 09/25/2008 | WO2008097428A3 Compounds and compositions as modulators of gpr119 activity |
| 09/25/2008 | WO2008067399A3 Controlled-release multi-layer formulation of piperazine-piperidine antagonists and agonists of the 5-th1a receptor having enhanced intestinal dissolution |
| 09/25/2008 | WO2008046919A3 Heterocyclic compounds and their use as glycogen synthase kinase 3 inhibitors |
| 09/25/2008 | WO2008027585A3 Pyrrolo[3,2-d]pyrimidines that are selective antagonists of a2b adenosine receptors |
| 09/25/2008 | US20080234340 Synthesis and characterization of polymorph form II of 4-(2-(4,4-dimethyl-2-oxooxazolidin-3-YL)thiazol-4-YL)benzonitrile |
| 09/25/2008 | US20080234292 Such as S)-(1-(1-Aminobicyclo[2.2.2]oct-4-yl)aminoacetyl)-2-cyanopyrrolidine; inhibitors of the enzyme dipeptidyl peptidase; antidiabetic agents |
| 09/25/2008 | US20080234288 Using compounds such as {3-[(2-Acetylamino-benzooxazole-6-sulfonyl)-isobutyl-amino]-1-benzyl-2-hydroxy-propyl}-carbamic acid thiazol-5-ylmethyl ester; HCV infections |
| 09/25/2008 | US20080234278 Beta-agonists, methods for the preparation thereof and their use as pharmaceutical compositions |
| 09/25/2008 | US20080234273 Such as 3-{[4-(azetidin-1-ylcarbonyl)-2-chlorophenyl]oxy}-5-({(1S)-2-[(difluoromethyl)oxy]-1-methylethyl}oxy)-N-(1-methyl-1H-pyrazol-3-yl)benzamide; glucokinases (Glk) |
| 09/25/2008 | US20080234271 Arylphenylamino- and Arylphenylether-Sulfide Derivatives, Useful For the Treatment of Inflammatory and Immune Diseases, and Pharmaceutical Compositions Containing Them |
| 09/25/2008 | US20080234270 For modulating activity of one or more steroid nuclear receptors and for treatment, prevention, or amelioration of symptoms of disease or disorder related to the activity of receptors; 5-benzo[b]thiophen-2-yl-1,4-dimethyl-1H-pyrrole-3-carboxylic acid (4-methanesulfonyl-phenyl)-amide |
| 09/25/2008 | US20080234269 N-Oxo-Heterocycle and N-Oxo-Alkyl Quinoline-4-Carboxamides as Nk-3 Receptor Ligands |
| 09/25/2008 | US20080234266 Squaric Acid Derivatives II |
| 09/25/2008 | US20080234263 Antiproliferative agent in the prevention or treatment of tumors which are sensitive to inhibition of EGF and erbB receptor tyrosine kinases;1-({4-[(3-chloro-2-fluorophenyl)amino]-7-methoxyquinazolin-6-yl}methyl)-L-prolinamide |
| 09/25/2008 | US20080234262 For treating Mammalian Target of Rapamycin (mTOR)-related disorders and phosphatidylinositol-3 kinase ("PI3K")-related disorders; N-{3-[1-(1-benzylpiperidin-4-yl)-4-morpholin-4-yl-1H-pyrazolo[3,4-d]pyrimidin-6-yl]phenyl}-N'-methylurea; anticarcinogenic agents, antiinflammatory agents |
| 09/25/2008 | US20080234259 CB2 agonists; pain, neurodegenative disorders, eating disorders, weight loss or control, obesity, dyslipidemia, drug abuse, vision defect, neurodegenerative diseases; 5-(2,4-difluorophenyl)-4,5-diazatricyclo[5.2.1.0.sup.2,6.]deca-2-(6),3-dien-3-yl-phenylmethanone; antiinflammatory agent, antidepressant |
| 09/25/2008 | US20080234258 Dihydroxyanthraquinones and Their Use |
| 09/25/2008 | US20080234250 Heterocyclic Condensed Compounds Useful as Antidiuretic Agents |
| 09/25/2008 | US20080233102 administering a transglutaminase inhibitor, particularly a compound with a 3-halo-dihydroisoxazole moiety or an analog of isatin, to attenuate gluten toxicity |
| 09/25/2008 | CA2682195A1 Aminopyrimidines useful as kinase inhibitors |
| 09/25/2008 | CA2681015A1 Inhibitors of focal adhesion kinase |
| 09/25/2008 | CA2680583A1 Pyridazinone derivatives useful as glucan synthase inhibitors |
| 09/25/2008 | CA2679138A1 Amino-pyridine derivatives as s1p1/edg1 receptor agonists |
| 09/24/2008 | EP1972625A1 Oxadiazole derivative and light-emitting element, light-emitting device, and electronic device in which the oxadiazole derivative is used |
| 09/24/2008 | EP1972624A1 Benzoxazinones and their use as ultraviolet light absorbers |
| 09/24/2008 | EP1971602A2 Niacin receptor agonists, compositions containing such compounds and methods of treatment |
| 09/24/2008 | EP1971601A2 N4-phenyl-quinazoline-4 -amine derivatives and related compounds as erbb type i receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases |